Showing results (51-60 of 61) with videos related to

Sort By:
Pageof 7
Leukemia Research|March 10, 1999
The effect of sclareol on growth and cell cycle progression of human leukemic cell linesK Dimas, D Kokkinopoulos, C Demetzos, et al.
Anticancer Research|January 11, 2000
Cytotoxic activity and antiproliferative effects of a new semi-synthetic derivative of Ent-3 beta-hydroxy-13-epi-manoyl oxide on human leukemic cell linesK Dimas, C Demetzos, S Mitaku, et al.
Human Reproduction (Oxford, England)|June 8, 1999
Purification of a candidate gonadotrophin surge attenuating factor from human follicular fluidA Pappa, K Seferiadis, T Fotsis, et al.
Archives of Toxicology|August 30, 2008
Inhibition of rat hepatic CYP2E1 by quinacrine: molecular modeling investigation and effects on 4-(methyl nitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-induced mutagenicityPetros Nikolaos Karamanakos, D T P Trafalis, G D Geromichalos, et al.
Plos One|October 15, 2015
Dopamine D2-Receptor Antagonists Down-Regulate CYP1A1/2 and CYP1B1 in the Rat LiverP Harkitis, E P Daskalopoulos, F Malliou, et al.
Behavioural Pharmacology|September 9, 2005
Behavioral pharmacological properties of a novel cannabinoid 1',1'-dithiolane delta8-THC analog, AMG-3K Antoniou, A Galanopoulos, S Vlachou, et al.
British Journal of Cancer|June 7, 2007
A dose escalation and pharmacokinetic study of biweekly pegylated liposomal doxorubicin, paclitaxel and gemcitabine in patients with advanced solid tumoursV Bozionelou, L Vamvakas, P Pappas, et al.
Cancer Chemotherapy and Pharmacology|March 3, 2007
Weekday on-weekend off oral capecitabine: a phase I study of a continuous schedule better simulating protracted fluoropyrimidine therapyG Pentheroudakis, P Pappas, V Golfinopoulos, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 9, 2012
Intracellular signalling via the AKT axis and downstream effectors is active and prognostically significant in cancer of unknown primary (CUP): a study of 100 CUP casesV Golfinopoulos, G Pentheroudakis, A Goussia, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 4, 2003
A dose-escalation and pharmacokinetic study of gemcitabine and oxaliplatin in patients with advanced solid tumorsD Mavroudis, P Pappas, C Kouroussis, et al.
Pageof 7